Fluticasone, Umeclidinium bromide, Vilanterol

Trelegy Ellipta

200 MCG / ACT + 62.5 MCG / ACT + 25 MCG / ACT PowderCanadaMarketedAuthorised 13 Sept 2021

In other countries

The same active substances on other registers, the same brand first.

Trelegy ElliptaEuropean Union · GlaxoSmithKline Trading Services LimitedSame brand
Trelegy ElliptaNew Zealand · Powder for inhalation fluticasone furoate 100 mcg with umeclidinium 62.5 mcg and vilanterol 25 mcgSame brand
Trelegy® Ellipta®Serbia · 92mcg+55mcg+22mcg · prašak za inhalaciju, podeljen · Evropa Lek Pharma D.O.O. BeogradSame brand
Trelegy® Ellipta®Serbia · 92mcg+55mcg+22mcg · prašak za inhalaciju, podeljen · Evropa Lek Pharma D.O.O. BeogradSame brand
TRELEGY ELLIPTA 100/62.5/25MCG Inhalation powder, pre-dispensedSaudi Arabia · Glaxo Operations UK LtdSame brand
Elebrato Ellipta 92 Microgramos/55 Microgramos/22 Microgramos Polvo Para Inhalacion (Unidosis)Spain · 92 µg + 55 µg + 22 µg · polvo para inhalación (unidosis) · Glaxosmithkline Trading Services LimitedSame substance

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Fluticasone, Umeclidinium bromide, Vilanterol

Trelegy Ellipta

200 MCG / ACT + 62.5 MCG / ACT + 25 MCG / ACT PowderCanadaMarketedAuthorised 13 Sept 2021

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Elebrato ElliptaEuropean Union · GlaxoSmithKline Trading Services Limited

Temybric ElliptaEuropean Union · GlaxoSmithKline Trading Services Limited

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Fluticasone, Umeclidinium bromide, Vilanterol
Strength: 200 MCG / ACT + 62.5 MCG / ACT + 25 MCG / ACT
Dosage form: Powder
Route: Inhalation
Register: Canada (Health Canada)
Status: Marketed
Authorised: 13 Sept 2021
Registration: DIN 02515776
Marketing authorisation holder: Glaxosmithkline INC
ATC code: R03AL08
Group: Respiratory system
Supply: PRESCRIPTION